Tim Fitzwater - Concepedia

Author

Tim Fitzwater

Nivalis Therapeutics (United States)

Also Known As

T Fitzwater, T. Fitzwater, Tim Fitzwater

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Nivalis Therapeutics (United States)Indiana University Bloomington SomaLogic (United States)The Rogosin Institute University of Colorado Boulder

About

Tim Fitzwater is an author at Nivalis Therapeutics (United States) specializing in medicine, molecular biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	932
2	Natural Sciences	5	5	475
3	Cell Biology	3	3	435
4	Biochemistry	2	2	416
5	Immunology	2	2	243

Tim Fitzwater

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery Larry Gold, Deborah Ayers, Jennifer Bertino, PLoS ONE	2010	1.7K
Aptamer-based multiplexed proteomic technology for biomarker discovery Larry Gold, Deborah Ayers, Jennifer Bertino, Nature Precedings	2010	376
Expanding the Chemistry of DNA for in Vitro Selection Jonathan D. Vaught, Chris Bock, Jeff Carter, Journal of the American Chemical Society GeneticsDna AnalysisMolecular BiologyUnique Amide LinkageNucleic Acid Chemistry	2010	305
Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor Nikos Pagratis, Carol Bell, Ying-Fon Chang, Nature Biotechnology Molecular BiologyKeratinocyte Growth FactorAntisense TherapyMedicineCell Biology	1997	214
[17] A SELEX primer Tim Fitzwater, Barry Polisky Methods in enzymology on CD-ROM/Methods in enzymology Reporting StandardA Selex PrimerStandardizationSpecification (Technical Standard)	1996	170
DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. Brian J. Hicke, Susan R. Watson, Andrea Koenig, Journal of Clinical Investigation Exponential EnrichmentImmunologyImmunologic MechanismSynthetic ImmunologyImmunogenetics	1996	132
Calcium-dependent oligonucleotide antagonists specific for L-selectin. D O'Connell, Andrea Koenig, Susan Jennings, Proceedings of the National Academy of Sciences Molecular PharmacologyExponential EnrichmentNatural LigandsMolecular PhysiologyDrug Targeting	1996	111
Transformation of Paramecium by microinjection of a cloned serotype gene. Ronald Godiska, K J Aufderheide, David Gilley, Proceedings of the National Academy of Sciences HistocompatibilityReverse GeneticsGeneticsMolecular BiologyAntigen Processing	1987	89
Isolation and characterization of 2'-fluoro-, 2'-amino-, and 2'-fluoro-/amino-modified RNA ligands to human IFN-γ that inhibit receptor binding Mark F. Kubik, Carol Bell, Tim Fitzwater, The Journal of Immunology	1997	78
Conditional high copy number ColE1 mutants: resistance to RNA1 inhibition in vivo and in vitro. Tim Fitzwater, X. Y. Zhang, Randolph C. Elble, The EMBO Journal Rna ProcessingTranscriptional RegulationGenome InstabilityMolecular ResearchMedicine	1988	39

Page 1